Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(3;6)(q25;q26)

Clinics and Pathology

Disease Acute myeloid leukaemia (AML) and treatment related acute myeloid leukaemia (t-AML)
Epidemiology Only 2 cases to date, a 41 year old female patient with M1 AML, and a 70 year old male patient with t-AML
Prognosis No data

Cytogenetics

Cytogenetics Morphological sole anomaly in the t-AML case, accompanied with del(7q) and a complex karyotype in the other case.

Genes involved and Proteins

Note The partner of EVI1 is yet unknown.
Gene Name EVI1
Location 3q26.2
Protein Transcrition factor; EVI1 targets include:GATA2, ZBTB16 /PLZF, ZFPM2/FOG2, JNK and the PI3K/AKT pathway. Role in cell cycle progression, likely to be cell-type dependant; antiapoptotic factor; involved in neuronal development organogenesis; role in hematopoietic differsntiation

External links

Other databaset(3;6)(q25;q26) Mitelman database (CGAP - NCBI)

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.

Bibliography

Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, De Paepe A, Speleman F
Genes, chromosomes & cancer. 2002 ; 33 (1) : 60-72.
PMID 11746988
 
EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.
Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N, De Paepe A, Cervera J, Recher C, De Mas V, Hagemeijer A, Speleman F
Genes, chromosomes & cancer. 2006 ; 45 (4) : 349-356.
PMID 16342172
 
The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.
Wieser R
Gene. 2007 ; 396 (2) : 346-357.
PMID 17507183
 

Contributor(s)

Written05-2007Jean-Loup Huret
Jean Loup HURET, Genetics, Dept Medical Information, University of Poitiers; CHU Poitiers Hospital, F-86021 Poitiers, France

Citation

This paper should be referenced as such :
Huret JL . t(3;6)(q25;q26). Atlas Genet Cytogenet Oncol Haematol. May 2007 .
URL : http://AtlasGeneticsOncology.org/Anomalies/t0306q25q26ID1211.html

This paper is referenced by INIST as such :
http://documents.irevues.inist.fr/bitstream/2042/38479/1/05-2007-t0306q25q26ID1211.pdf   [ Bibliographic record ]

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Mar 9 12:36:58 CET 2013

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.